Rite Aid, CVS sue 3 drugmakers for blocking generics


Rite Aid and CVS Pharmacy filed a civil antitrust suit against Gilead Sciences, Teva Pharmaceuticals and Bristol-Myers Squibb accusing the drugmakers of paying potential generic drug rivals with cash or services to delay the market entry of generic versions of their blockbuster drugs, including Gilead's hepatitis B drug Vemlidy and HIV treatments Atripla, Descovy, Truvada and Viread. The lawsuit claims Gilead and Bristol use the reverse payment scheme to force insurers and patients to overpay millions for their drugs.

Full story:

FDLI SmartBrief

The latest regulatory and company news on food, drugs, animal drugs, biologics, cosmetics, diagnostics, dietary supplements, medical devices and tobacco

Designed specifically for professionals involved in the food and drug law community, FDLI SmartBrief is a FREE daily e-mail newsletter. It provides the latest need-to-know news and industry information that maximizes your time, giving you an edge over your competition.